Dr. María Victoria Mateos from Salamanca has just won the 2026 Lilly Award. Her work has changed the rules of the game for multiple myeloma, that treacherous bone marrow cancer. Now, between 60% and 75% of patients respond better to treatment and gain quality of life. It's not magic, it's applied science with intelligence and perseverance.
The revolution of targeted therapies 🧬
The key to her success lies in monoclonal antibodies and immunotherapies. Mateos has managed to fine-tune the aim against cancerous plasma cells without wiping out healthy ones. Additionally, she has optimized drug combinations and treatment sequences. This allows for personalized combat, extended survival, and reduced side effects that once turned therapy into an ordeal.
Meanwhile, myeloma still doesn't make an appointment 🎯
Of course, cancer, stubborn as it is, doesn't care about awards or calendars. But thanks to Mateos, when it knocks on the door, it now finds a more efficient doorman. Patients no longer have to choose between living longer or living better. Science advances, and even if the bug doesn't disappear completely, at least it learns to behave a little better. That is, without quotation marks.